Agnes Hamzaoui

Agnes Hamzaoui

Auto-generated profile, based on publicly available information

Agnes Hamzaoui


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Immunobiology
Verified
Journal Article
Closed access
AHAgnes Hamzaoui
Agnes Hamzaoui
ABAnissa Berraïes
Anissa Berraïes
BHBesma Hamdi
Besma Hamdi
WKWajih Kaabachi
Wajih Kaabachi
JAJamel Ammar
Jamel Ammar
KHKamel Hamzaoui
Kamel Hamzaoui

1 April 2014 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
AHAgnes Hamzaoui
Agnes Hamzaoui
ABAnissa Berraies
Anissa Berraies
KHKamel Hamzaoui
Kamel Hamzaoui
In the last decade, many epidemiologic studies have investigated the link between vitamin D deficiency and asthma. Most studies have shown that vitamin D deficiency increases the risk of asthma and allergies. Low levels of vitamin D have been associated with asthma severity and loss of control, together with recurrent exacerbations. Remodeling is an early event in asthma described as a consequence of production of mediators and growth factors by inflammatory and resident bronchial cells. Consequently, lung function is altered, with a decrease in forced expiratory volume in one second and exacerbated airway hyperresponsiveness. Subepithelial fibrosis and airway smooth muscle cell hypertrophy are typical features of structural changes in the airways. In animal models, vitamin D deficiency enhances inflammation and bronchial anomalies. In severe asthma of childhood, major remodeling is observed in patients with low vitamin D levels. Conversely, the antifibrotic and antiproliferative effects of vitamin D in smooth muscle cells have been described in several experiments. In this review, we briefly summarize the current knowledge regarding the relationship between vitamin D and asthma, and focus on its effect on airway remodeling and its potential therapeutic impact for asthma.

9 October 2017 in Lung
Verified
Journal Article
Closed access
PDF file
RCRihab Charrad
Rihab Charrad
WKWajih Kaabachi
Wajih Kaabachi
ARAhlem Rafrafi
Ahlem Rafrafi
ABAnissa Berraies
Anissa Berraies
KHKamel Hamzaoui
Kamel Hamzaoui
AHAgnes Hamzaoui
Agnes Hamzaoui

31 August 2014 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
AHAgnes Hamzaoui
Agnes Hamzaoui
SYSadok Yaalaoui
Sadok Yaalaoui
FCFatma Tritar Cherif
Fatma Tritar Cherif
LSLeila Slim Saidi
Leila Slim Saidi
ABAnissa Berraies
Anissa Berraies

1 February 2020 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
SLSabrine Louhaichi
Sabrine Louhaichi
MMMona Mlika
Mona Mlika
BHBesma Hamdi
Besma Hamdi
KHKamel Hamzaoui
Kamel Hamzaoui
AHAgnes Hamzaoui
Agnes Hamzaoui
Objective: Asthma inflammation is a complex pathway involving numerous mediators. Interleukin-26 (IL-26), a member of the IL-10 cytokine family, is abundant in human airways and induces the production of proinflammatory cytokines. Our aim was to investigate the possible role of IL-26 in severe asthma. We analysed the expression of IL-26 in severe asthma both in peripheral blood and induced sputum. Patients and Methods: A total of 50 adult women with severe asthma were recruited and compared to 30 healthy controls (HC). Serum and sputum fluid (SF) levels of IL-26 and IL-17 were defined by ELISA. IL-26 mRNA expression and IL-26 protein were analysed using RT-PCR and Western blot. In vitro, we studied the effect of recombinant IL-26 (rIL-26) and SF-IL-26 on cultured CD4+ T cells and monocytes, comparing patients and controls. Results: Concentrations of IL-26 are higher in serum and induced sputum of asthmatic patients than in HC. Moreover, IL-26 protein and mRNA expression were significantly elevated in asthma sputum cells compared to PBMCs. We observed a positive correlation between body mass index (BMI) and sputum fluid IL-26, while the correlation between IL-26 and lung function tests (FEV1% and FEV1/FVC ratio) was negative. IL-17A was highly expressed in SF and correlated positively with IL-26. In patients’ sputum IL-26 and IL-17A were significantly associated with neutrophils. Stimulation of cultured CD4+ T cells with monocytes by recombinant IL-26 promoted the generation of RORγt+ Th17+ cells inducing the production of IL-17A, IL-1β, IL-6 and TNF-α cytokines. IL-26 expressed in SF was biologically active and induced IL-17 secretion in the presence of IL-1β and IL-6 cytokines. Conclusion: These findings show that IL-26 is highly produced in asthmatic sputum, induces pro-inflammatory cytokine secretion by monocytes/macrophages, and favours Th17 cell generation. IL-26 thereby appears as a novel pro-inflammatory cytokine, produced locally in the airways that may constitute a promising target to treat asthma inflammatory process.

1 January 2012 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
KHKamel Hamzaoui
Kamel Hamzaoui
HAHanadi Abid
Hanadi Abid
ABAnissa Berraies
Anissa Berraies
JAJamel Ammar
Jamel Ammar
AHAgnès Hamzaoui
Agnès Hamzaoui
Excessive Th1 cells and TLRs functions are involved in the pathogenesis of Behcet's disease (BD) in response to bacterial antigens. NOD2, an intracellular pathogen recognition sensor, modulates innate defence to muropeptides derived from various bacterial species. To further define a role for NOD2 in BD, we analysed NOD2 transcriptional responses in BAL-MNC from BD patients with pulmonary manifestations.